Abivax (ABVX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 1,221 | 2,908 |
| Marketable Securities | 1,703 | 400 |
| Receivables | 2,389 | 2,246 |
| Other current assets | 327 | 26 |
| TOTAL | $5,640 | $5,600 |
| Non-Current Assets | ||
| PPE Net | 231 | 66 |
| Investments And Advances | 86 | 42 |
| Intangibles | 32,009 | 32,754 |
| TOTAL | $32,326 | $32,863 |
| Total Assets | $37,966 | $38,463 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 1,050 | 1,562 |
| TOTAL | $1,892 | $2,121 |
| Non-Current Liabilities | ||
| Long Term Debt | 1 | N/A |
| Other Non-Current Liabilities | 2,138 | 2,323 |
| TOTAL | $2,139 | $2,323 |
| Total Liabilities | $4,031 | $4,444 |
| Shareholders' Equity | ||
| Common Shares | 69 | N/A |
| Retained earnings | -5,091 | N/A |
| Other shareholders' equity | 3,282 | 34,019 |
| TOTAL | $33,935 | $34,019 |
| Total Liabilities And Equity | $37,966 | $38,463 |